The OmniTom Elite with PCD will be piloted to monitor post-trauma and post-surgical patients
NeuroLogica has collaborated with Massachusetts General Hospital to pilot OmniTom Elite with PCD technology at patient point-of-care. (Credit: Business Wire)
Samsung Electronics healthcare subsidiary NeuroLogica has entered into a research collaboration with Massachusetts General Hospital to pilot OmniTom Elite system with Photon Counting Detector (PCD) technology.
In partnership with Samsung, the NeuroLogica research and development team has designed the OmniTom Elite with PCD in Danvers, Massachusetts.
The OmniTom Elite with PCD, for which FDA 510(k) clearance is pending, will be piloted at Massachusetts General Hospital to monitor post-trauma and post-surgical patients.
It will help provide multi-energy computed tomography (CT) imaging to the patient’s point-of-care.
NeuroLogica said that OmniTom Elite CT system, which is designed for CT applications, has been upgraded with PCD technology.
Massachusetts General Hospital ultra-high-resolution volume CT lab director Dr Raj Gupta said: “This will be the first time where multi-spectral imaging will be used inside of the intensive care unit. We are particularly interested in how this technology can help guide patient care decisions through quantitative image analysis.”
Photon counting is a next generation CT technology, which holds the potential to sort the different energies of X-rays after they have passed through the scan field. At the same time, the multiple sets of CT data are captured with configurable energy thresholds.
It will help precisely visualise and segment bone, blood clots, plaque, hemorrhage, and intracranial tumor in critical intensive care unit (ICU) patients when in use with the OmniTom Elite scanner.
The PCD technology also holds capacity to fundamentally change the use of injected contrast agents, which highlight blood vessels by collecting high signal even at low contrast agent dosage.
In addition, the PCD has the ability to capture CT data in multiple energy bands, which helps to offer information on material composition of different tissues and contrast media.
NeuroLogica chief operating officer David Webster said: “Since the advent of point-of-care CT in 2004 by NeuroLogica, we have always known that point-of-care imaging can improve patient outcomes and increase the likelihood of a better post-traumatic quality of life.
“With the introduction of Photon Counting to the OmniTom Elite platform, we hope to expand the diagnostic possibilities of computed tomography at the patient’s bedside.”
With its ability to offer real-time mobile imaging, the OmniTom Elite allows healthcare providers to administer point-of-care CT to critical patients without moving them to a separate department.